"Providence Brain and Spine Institute is a comprehensive, integrated center of excellence that treats all conditions of the brain and spine. We work with referring physicians and our patients to design treatment and rehabilitation plans focused on each patient’s needs."

During the past decade, Providence Brain and Spine Institute conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 6 clinical trials were completed, i.e. on average, 35.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Brain and Spine Institute" #1 sponsor was "Pfizer" with 5 trials, followed by "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "ZevraDenmark" with 2 trials sponsored, "Anelixis Therapeutics, LLC" with 1 trials sponsored and "Biogen" with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Brain and Spine Institute" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 1 trials as a collaborator, "Beijing Tiantan Hospital" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Providence Brain and Spine Institute" are "Amyotrophic Lateral Sclerosis" (5 trials), "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (3 trials), "Intracerebral Hemorrhage" (2 trials) and "Acute Treatment of Migraine" (1 trials). Many other conditions were trialed in "Providence Brain and Spine Institute" in a lesser frequency.

Most popular intervention types in "Providence Brain and Spine Institute" are "Drug" (22 trials), "Device" (3 trials), "Diagnostic Test" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bapineuzumab 0.5 mg/kg" (3 trials), "placebo" (3 trials), "Arimoclomol" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "Placebo Control" (2 trials). Other intervention names were less common.

The vast majority of trials in "Providence Brain and Spine Institute" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Providence Brain and Spine Institute". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Providence Brain and Spine Institute, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Brain and Spine Institute, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".